Dianthus Therapeutics | MGTA - 销售收入



金融业
股票价格
USD
资产
USD 530.92M
现金及等价物
USD 51.09M
流动资产
USD 409.44M
流动负债
USD 30.73M
债务
USD 1.29M
EBIT
USD -40.29M
EBITDA
USD -40.19M
员工
53
EPS每股收益
USD -0.97
股本和储备
USD 493.4M
销售毛利
USD 396K
债务利息支出
USD 4.45M
利息收入
USD 3.66M
贷款资金
USD 0
市值
USD 2.32B
净收入
USD -36.76M
营业费用
USD 40.68M
营业利润
USD -40.29M
普通股股本
USD 42.85M
税前利润
USD -36.76M
销售收入
USD 396K
销售和管理费用
USD 8.2M
股票
384K
贸易债权人
USD 9.73M
应收帐款人
USD 5M


销售 更改 日
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Avita Medical AUD 17.61M 805K 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.62B 358.95M 2025-09
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 396K 203K 2025-09
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 121.55M 14.19M 2025-09
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 678M 342M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 80.06M 9.27M 2025-09
Organon & Co USD 1.51B 90M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 17.57B 4.58B 2025-06
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.7B 60M 2025-12
Xeris Pharmaceuticals USD 74.38M 2.84M 2025-09
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09